Description

BSE notifies trading members that Kalpalabdhi Financials Private Limited (Clg no. 6678) will replace SVCM Securities Private Limited (Clg. No. 6737) as Market Maker for Clinitech Laboratory Ltd, effective April 14, 2026.

Summary

BSE has notified trading members that the Market Maker for Clinitech Laboratory Ltd (Scrip Code: 544220) on the SME segment is being changed. SVCM Securities Private Limited (Clg. No. 6737) will cease to act as Market Maker, and Kalpalabdhi Financials Private Limited (Clg. No. 6678) will assume the role effective April 14, 2026.

Key Points

  • SVCM Securities Private Limited (Clg. No. 6737) will no longer serve as Market Maker for Clinitech Laboratory Ltd (Scrip Code: 544220)
  • Kalpalabdhi Financials Private Limited (Clg. No. 6678) has entered into a new agreement with the company to act as its Market Maker
  • The new Market Maker will fulfill all duties and obligations of Market Making as required under BSE SME segment rules
  • Change is effective from April 14, 2026

Regulatory Changes

No regulatory changes. This is an administrative notice informing trading members of a change in the designated Market Maker for a listed SME company.

Compliance Requirements

  • Kalpalabdhi Financials Private Limited (Clg. No. 6678) is required to comply with all duties and obligations of Market Making for Clinitech Laboratory Ltd from April 14, 2026 onwards
  • Trading members of the Exchange are advised to take note of this change

Important Dates

  • Notice Date: April 13, 2026
  • Effective Date: April 14, 2026 — Kalpalabdhi Financials Private Limited takes over as Market Maker

Impact Assessment

This change has minimal market impact. It is a routine administrative transition of the market-making function for a single SME-listed company (Clinitech Laboratory Ltd). The continuity of market-making obligations is maintained as a new entity (Kalpalabdhi Financials Private Limited) assumes the role immediately upon the previous firm’s exit. Investors and traders in the scrip should not experience any disruption in liquidity support.

Impact Justification

Routine administrative change of market maker for a single SME-listed company; no regulatory change or broad market impact.